In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CVRx: Can Devices Succeed Where Drugs Fail for High Blood Pressure?

Executive Summary

With hypertension reaching pandemic proportions, more and more people are not successfully treated with the drugs that, until now, have been the only therapy. CVRx is the first to develop a device to provide patients with another option.
Advertisement

Related Content

CVRx’s Hypertension Implant Gains FDA Humanitarian Exemption
Ardian: Succeeding Where Drugs Fail--Treating Hypertension in the Cath Lab
Medtech Investing 2009: What's Changed?
ESC Highlights: Imaging, Hypertension Devices Take Center Stage
Institutional Innovation in Devices
Asthmatx Breathes Easier
ev3: The Virtues of Focus
The Cardio-Renal Connection
Northstar's Buzz
Ev3 Goes Global

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002988

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel